Acumen Pharmaceuticals annual current ratio
2021
2022
2023
2024
2025
Acumen Pharmaceuticals Current Ratio Growth & History (ABOS)
Acumen Pharmaceuticals's current ratio was 4.07 for fiscal 2025.
View full Acumen Pharmaceuticals company overviewAcumen Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.07 | −2.38 | −36.92% |
| 2024 | 2024-12-31 | 6.46 | −12.55 | −66.03% |
| 2023 | 2023-12-31 | 19.01 | −4.07 | −17.64% |
| 2022 | 2022-12-31 | 23.08 | −15.51 | −40.19% |
| 2021 | 2021-12-31 | 38.60 | — | — |
Acumen Pharmaceuticals quarterly current ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.47 | −3.50 | −58.69% |
| Q1 2026 | 2026-03-31 | 4.55 | −3.47 | −43.24% |
| Q4 2025 | 2025-12-31 | 4.07 | −2.38 | −36.92% |
| Q3 2025 | 2025-09-30 | 6.02 | −4.41 | −42.27% |
| Q2 2025 | 2025-06-30 | 5.97 | −11.40 | −65.63% |
| Q1 2025 | 2025-03-31 | 8.02 | −22.18 | −73.43% |
| Q4 2024 | 2024-12-31 | 6.46 | −12.55 | −66.03% |
| Q3 2024 | 2024-09-30 | 10.43 | −25.42 | −70.91% |
| Q2 2024 | 2024-06-30 | 17.37 | −0.16 | −0.91% |
| Q1 2024 | 2024-03-31 | 30.20 | 13.79 | +84.06% |
| Q4 2023 | 2023-12-31 | 19.01 | −4.07 | −17.64% |
| Q3 2023 | 2023-09-30 | 35.85 | 5.22 | +17.03% |
| Q2 2023 | 2023-06-30 | 17.53 | −19.68 | −52.90% |
| Q1 2023 | 2023-03-31 | 16.41 | −32.40 | −66.38% |
| Q4 2022 | 2022-12-31 | 23.08 | −15.51 | −40.19% |
| Q3 2022 | 2022-09-30 | 30.63 | — | — |
| Q2 2022 | 2022-06-30 | 37.21 | — | — |
| Q1 2022 | 2022-03-31 | 48.81 | — | — |
| Q4 2021 | 2021-12-31 | 38.60 | — | — |
Acumen Pharmaceuticals current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Acumen Pharmaceuticals's current ratio decreased from 38.60 to 4.07, a change of −34.52. The latest reported quarter, Q2 2026, shows 2.47.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acumen Pharmaceuticals source filings ↗